ValueAct Holdings, L.P.

Q2 2021 13F Combination Report, New Holdings, Stock Holdings

Notable people
Jeffrey Ubben
Signature - Title
Jason B. Breeding - Authorized Signatory
Location
San Francisco, CA
Holdings as of
June 30, 2021
Value $
$658M
Num holdings
1
Date filed
8/19/2021, 02:01 PM
Description
Request for Confidential Treatment (8/16/2021): Confidential Treatment Expired on 8/19/2021. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2021 - May 17, 2021
Next filing
Q3 2021 - Nov 15, 2021
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 08-16-2021 pursuant to a request for confidential treatment and for which confidential treatment expired on 08-19-2021.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Jason B. Breeding Authorized Signatory San Francisco, California 8/19/2021

List of Other Managers Reporting for ValueAct Holdings, L.P.:

Name Holdings Value Location File Number
ValueAct Capital Management, L.P. San Francisco, CA 028-12033

Other Included Managers (1):

Num Name Location File Number
1 ValueAct Capital Management, L.P. San Francisco, CA